問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Nuclear Medicine

Taoyuan Chang Gung Memorial Hospital of The C.G.M.F. (在職)

Division of Nuclear Medicine

更新時間:2023-09-24

林昆儒Lin, Kun-Ju
  • Principal Investigator
  • Clinical Trial Experience (year) 22 years 9 個月

篩選

List

70Cases

2020-01-01 - 2023-12-31

Phase II

Image characteristic and longitudinal follow up of 18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear Palsy
  • Condition/Disease

    Progressive Supranuclear Palsy

  • Test Drug

    18F-PMPBB3 (別名APN-1607, MNI-958, or APN-0000455)

Participate Sites
1Sites

Recruiting1Sites

2014-08-01 - 2017-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2014-08-01 - 2017-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2014-05-21 - 2017-07-31

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2015-08-01 - 2016-07-31

Phase I

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

林昆儒
Linkou Chang Gung Medical Foundation

Division of Nuclear Medicine

2015-10-01 - 2017-09-30

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2015-08-01 - 2018-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2016-07-01 - 2023-05-09

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites

2017-08-01 - 2020-07-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2017-08-01 - 2021-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Recruiting1Sites